U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT03835663) titled 'The Bacterial Composition of the Stomach in Reflux Disease' on Jan. 31.
Brief Summary: Gastric and oesophageal (OG) cancer associated with poor long term outcome as overall less than 25% of patients survive for more than 5 years due to late recognition of the disease. Growing evidence suggests an important role for bacteria in OG cancer and gastro esophageal reflux disease (GORD) development. About 1 in 10 people suffer from GORD and this one of the most common conditions leading to gastric and oesophageal cancer.
In GORD surgical therapy is the most successful preventing cancer but around 85% of patient experience complications af...